The development of mortality due to pleural mesothelioma in France

The French health watch institute (InVS) worked in partnership with the Inserm unit “Epidemiological Center for Mortality by Medical Causes” to publish the results of models they had produced showing the development of mortality due to pleural mesothelioma in France, based on the latest data available in France. Models had been produced at the end of the nineties. These were brought up to date. This work gave encouraging results, but are to be taken with caution.

Read the report on the InVS site

Inserm press room The development of mortality due to pleural mesothelioma in France Link : https://presse.inserm.fr/en/the-development-of-mortality-due-to-pleural-mesothelioma-in-france/6677/

Medias

Researcher Contact

Grégroire Rey Directeur de recherche Inserm au CépiDc +33(0)1 45 59 18 63 gregoire.rey@inserm.fr Didier Jean Chargé de recherche Inserm Unité Inserm 674 "Génétique fonctionnelle des tumeurs solides" Responsable de l'équipe "tumeurs mésothéliales et meningées" +33(0)1 53 72 51 89 didier.jean@inserm.fr

The development of mortality due to pleural mesothelioma in France

Researcher Contact

New Antibiotics Developed by Inserm and Université de Rennes 1

A novel, more effective method for diagnosing Alzheimer’s disease

Elaboration et validation de l’iBox, le premier outil universel de prédiction du risque de perte de rein greffé basé sur l’intelligence artificielle.

Du nouveau dans l’apprentissage automatique via des systèmes biologiques